Monday, November 21, 2011
Health Canada reviews Avastin after FDA pulls approval for breast cancer drug
OTTAWA - Health Canada is actively reviewing the drug Avastin to determine whether the benefits outweigh the risks as a treatment for advanced breast cancer. The U.S....More
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment